Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by hormones, illness, autoimmune disorders, or vitamin deficiencies, and treatments vary depending on the type.

New hair loss treatments could be improved by using combined biological markers.

Low zinc levels might be linked to worse outcomes in various skin disorders.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

Skin diseases are common and need more specialized care.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Lichen planopilaris is more common in older women and may be linked to hormone therapy and autoimmune diseases.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The document provides a comprehensive guide for dermatologists to diagnose and treat hair loss.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

Hair follicles prevent NK cell attacks to avoid hair loss.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.